• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

可吸入的低密度微颗粒由气溶胶化的脆性基质原位形成。

Respirable low-density microparticles formed in situ from aerosolized brittle matrices.

机构信息

Drug Dynamics Institute, The University of Texas at Austin, 1 University Station, Mail Stop A1915, Austin, Texas 78712, USA.

出版信息

Pharm Res. 2013 Mar;30(3):813-25. doi: 10.1007/s11095-012-0922-2. Epub 2012 Nov 15.

DOI:10.1007/s11095-012-0922-2
PMID:23229856
Abstract

PURPOSE

Inhalation of low-density porous particles enables deep lung delivery with less dependence on device design and patient inspiration. The purpose of this study was to implement Thin Film Freezing (TFF) to investigate a novel approach to dry powder inhalation.

METHODS

Powders produced by TFF were evaluated for aerodynamic and geometric particle size by cascade impaction and laser light scattering, respectively. Density measurements were conducted according to USP methods and calculated using data from particle size measurements. Excipient inclusion and its effect on moisture sorption was measured by Dynamic Vapor Sorption (DVS).

RESULTS

TFF-produced brittle matrix powders were sheared apart into respirable microparticles using a passive DPI device, producing fine particle fractions (FPF) up to 69% and mass median aerodynamic diameters (MMAD) as low as 2.6 μm. Particles had a mean geometric diameter ranging from 25 μm to 50 μm and mass densities of approximately 0.01 g/cm(3). Powders were susceptible to moisture-induced matrix collapse, capillary forces and electrostatic charging; although formulations containing mannitol or no sugar excipient proved to be more robust.

CONCLUSIONS

Aerosolized brittle matrices produced by TFF may prove to be a useful platform for highly efficient pulmonary delivery of thermally labile, highly potent, and poorly soluble drugs.

摘要

目的

吸入低密度多孔颗粒可以实现更深入的肺部输送,而对设备设计和患者吸气的依赖性较小。本研究的目的是采用薄膜冷冻(TFF)技术来探索干粉吸入的新方法。

方法

通过级联撞击和激光光散射分别对 TFF 制得的粉末进行空气动力学和几何粒径评估。根据 USP 方法进行密度测量,并使用粒径测量数据进行计算。通过动态蒸汽吸附(DVS)测量赋形剂的包含及其对吸湿性的影响。

结果

使用被动 DPI 装置将 TFF 制得的脆性基质粉末剪切为可吸入的微粉,产生高达 69%的细颗粒分数(FPF)和低至 2.6μm 的质量中值空气动力学直径(MMAD)。颗粒的平均几何直径范围为 25μm 至 50μm,质量密度约为 0.01g/cm³。粉末容易受到水分引起的基质塌陷、毛细作用力和静电充电的影响;尽管含有甘露醇或无糖赋形剂的配方表现出更强的稳定性。

结论

TFF 制得的雾化脆性基质可能成为一种有用的平台,可用于高效肺部输送热敏、高活性和难溶性药物。

相似文献

1
Respirable low-density microparticles formed in situ from aerosolized brittle matrices.可吸入的低密度微颗粒由气溶胶化的脆性基质原位形成。
Pharm Res. 2013 Mar;30(3):813-25. doi: 10.1007/s11095-012-0922-2. Epub 2012 Nov 15.
2
Design, characterization, and aerosol dispersion performance modeling of advanced co-spray dried antibiotics with mannitol as respirable microparticles/nanoparticles for targeted pulmonary delivery as dry powder inhalers.以甘露醇为可吸入微粒/纳米颗粒的先进共喷雾干燥抗生素作为干粉吸入剂用于靶向肺部给药的设计、表征和气溶胶分散性能建模
J Pharm Sci. 2014 Sep;103(9):2937-2949. doi: 10.1002/jps.23955. Epub 2014 Apr 16.
3
In vitro and in vivo performance of dry powder inhalation formulations: comparison of particles prepared by thin film freezing and micronization.干粉吸入制剂的体外和体内性能:薄膜冷冻法与微粉化法制备颗粒的比较
AAPS PharmSciTech. 2014 Aug;15(4):981-93. doi: 10.1208/s12249-014-0126-7. Epub 2014 May 14.
4
Aerosolizable Plasmid DNA Dry Powders Engineered by Thin-film Freezing.薄膜冷冻工程化的可气溶胶化质粒 DNA 干粉
Pharm Res. 2023 May;40(5):1141-1152. doi: 10.1007/s11095-023-03473-5. Epub 2023 Jan 26.
5
Pharmaceutical dry powders of small molecules prepared by thin-film freezing and their applications - A focus on the physical and aerosol properties of the powders.通过薄膜冷冻制备的小分子药物干粉及其应用——聚焦于粉末的物理和气溶胶性质。
Int J Pharm. 2022 Dec 15;629:122357. doi: 10.1016/j.ijpharm.2022.122357. Epub 2022 Nov 1.
6
Enhanced Aerosolization of High Potency Nanoaggregates of Voriconazole by Dry Powder Inhalation.高浓度伏立康唑纳米聚集体干粉吸入剂的气溶胶化增强作用。
Mol Pharm. 2019 May 6;16(5):1799-1812. doi: 10.1021/acs.molpharmaceut.8b00907. Epub 2019 Apr 10.
7
Formulation and physical characterization of large porous particles for inhalation.用于吸入的大孔颗粒的配方及物理特性
Pharm Res. 1999 Nov;16(11):1735-42. doi: 10.1023/a:1018910200420.
8
Impact of excipient choice on the aerodynamic performance of inhalable spray-freeze-dried powders.辅料选择对吸入式喷雾冷冻干燥粉末空气动力学性能的影响。
Int J Pharm. 2020 Aug 30;586:119564. doi: 10.1016/j.ijpharm.2020.119564. Epub 2020 Jun 23.
9
Protection of hydrophobic amino acids against moisture-induced deterioration in the aerosolization performance of highly hygroscopic spray-dried powders.保护疏水性氨基酸,防止高吸湿性喷雾干燥粉末的雾化性能因水分引起的劣化。
Eur J Pharm Biopharm. 2017 Oct;119:224-234. doi: 10.1016/j.ejpb.2017.06.023. Epub 2017 Jun 24.
10
The applications of Machine learning (ML) in designing dry powder for inhalation by using thin-film-freezing technology.机器学习(ML)在使用无薄膜冷冻技术设计干粉吸入剂中的应用。
Int J Pharm. 2022 Oct 15;626:122179. doi: 10.1016/j.ijpharm.2022.122179. Epub 2022 Sep 7.

引用本文的文献

1
Progress on Thin Film Freezing Technology for Dry Powder Inhalation Formulations.用于干粉吸入制剂的薄膜冷冻技术进展
Pharmaceutics. 2022 Nov 28;14(12):2632. doi: 10.3390/pharmaceutics14122632.
2
Spray freeze dried niclosamide nanocrystals embedded dry powder for high dose pulmonary delivery.喷雾冷冻干燥的氯硝柳胺纳米晶体包埋干粉用于高剂量肺部给药。
Powder Technol. 2023 Feb 1;415:118168. doi: 10.1016/j.powtec.2022.118168. Epub 2022 Dec 13.
3
Cannabinoid Formulations and Delivery Systems: Current and Future Options to Treat Pain.

本文引用的文献

1
Highly supersaturated solutions from dissolution of amorphous itraconazole microparticles at pH 6.8.在pH 6.8条件下,无定形伊曲康唑微粒溶解形成的高度过饱和溶液。
Mol Pharm. 2009 Mar-Apr;6(2):375-85. doi: 10.1021/mp800106a.
2
Templated open flocs of nanorods for enhanced pulmonary delivery with pressurized metered dose inhalers.用于通过压力定量吸入器增强肺部给药的纳米棒模板化开放絮状物。
Pharm Res. 2009 Jan;26(1):101-17. doi: 10.1007/s11095-008-9707-z. Epub 2008 Aug 29.
3
A comparison of the puncturing properties of gelatin and hypromellose capsules for use in dry powder inhalers.
大麻素制剂和给药系统:治疗疼痛的当前和未来选择。
Drugs. 2021 Sep;81(13):1513-1557. doi: 10.1007/s40265-021-01579-x. Epub 2021 Sep 4.
4
Pulmonary Drug Delivery of Antimicrobials and Anticancer Drugs Using Solid Dispersions.使用固体分散体进行抗菌药物和抗癌药物的肺部给药
Pharmaceutics. 2021 Jul 10;13(7):1056. doi: 10.3390/pharmaceutics13071056.
5
A Safety and Tolerability Study of Thin Film Freeze-Dried Tacrolimus for Local Pulmonary Drug Delivery in Human Subjects.人用局部肺部给药的薄膜冻干他克莫司安全性和耐受性研究
Pharmaceutics. 2021 May 13;13(5):717. doi: 10.3390/pharmaceutics13050717.
6
Next-Generation COVID-19 Vaccines Should Take Efficiency of Distribution into Consideration.下一代 COVID-19 疫苗应考虑分发效率。
AAPS PharmSciTech. 2021 Apr 9;22(3):126. doi: 10.1208/s12249-021-01974-3.
7
Development of Remdesivir as a Dry Powder for Inhalation by Thin Film Freezing.通过薄膜冷冻法开发吸入用瑞德西韦干粉剂。
Pharmaceutics. 2020 Oct 22;12(11):1002. doi: 10.3390/pharmaceutics12111002.
8
Intranasal immunization with aluminum salt-adjuvanted dry powder vaccine.鼻腔内免疫接种用铝盐佐剂干粉疫苗。
J Control Release. 2018 Dec 28;292:111-118. doi: 10.1016/j.jconrel.2018.10.020. Epub 2018 Oct 16.
9
The immunogenicity of thin-film freeze-dried, aluminum salt-adjuvanted vaccine when exposed to different temperatures.薄膜冷冻干燥、铝盐佐剂疫苗在暴露于不同温度时的免疫原性。
Hum Vaccin Immunother. 2017 Apr 3;13(4):936-946. doi: 10.1080/21645515.2016.1259042. Epub 2017 Jan 4.
10
A method of lyophilizing vaccines containing aluminum salts into a dry powder without causing particle aggregation or decreasing the immunogenicity following reconstitution.一种将含铝盐的疫苗冻干成干粉的方法,该方法不会导致颗粒聚集,也不会在重构后降低免疫原性。
J Control Release. 2015 Apr 28;204:38-50. doi: 10.1016/j.jconrel.2015.02.035. Epub 2015 Feb 28.
用于干粉吸入器的明胶胶囊和羟丙甲纤维素胶囊穿刺特性的比较。
Drug Dev Ind Pharm. 2008 Aug;34(8):870-6. doi: 10.1080/03639040801928903.
4
High bioavailability from nebulized itraconazole nanoparticle dispersions with biocompatible stabilizers.具有生物相容性稳定剂的雾化伊曲康唑纳米颗粒分散体具有高生物利用度。
Int J Pharm. 2008 Sep 1;361(1-2):177-88. doi: 10.1016/j.ijpharm.2008.05.003. Epub 2008 May 14.
5
Inhaled insulin's last gasp?吸入式胰岛素的最后一搏?
Nat Biotechnol. 2008 May;26(5):479-80. doi: 10.1038/nbt0508-479.
6
Nebulization of nanoparticulate amorphous or crystalline tacrolimus--single-dose pharmacokinetics study in mice.纳米颗粒无定形或结晶他克莫司的雾化——小鼠单剂量药代动力学研究
Eur J Pharm Biopharm. 2008 Aug;69(3):1057-66. doi: 10.1016/j.ejpb.2008.01.037. Epub 2008 Feb 16.
7
Amorphous cyclosporin nanodispersions for enhanced pulmonary deposition and dissolution.用于增强肺部沉积和溶解的无定形环孢素纳米分散体。
J Pharm Sci. 2008 Nov;97(11):4915-33. doi: 10.1002/jps.21367.
8
Fluticasone and budesonide nanosuspensions for pulmonary delivery: preparation, characterization, and pharmacokinetic studies.用于肺部给药的氟替卡松和布地奈德纳米混悬液:制备、表征及药代动力学研究。
J Pharm Sci. 2008 Nov;97(11):4869-78. doi: 10.1002/jps.21380.
9
Targeted intestinal delivery of supersaturated itraconazole for improved oral absorption.通过靶向肠道递送过饱和伊曲康唑来改善口服吸收。
Pharm Res. 2008 Jun;25(6):1450-9. doi: 10.1007/s11095-008-9543-1.
10
Formation of stable submicron protein particles by thin film freezing.通过薄膜冷冻法形成稳定的亚微米蛋白质颗粒。
Pharm Res. 2008 Jun;25(6):1334-46. doi: 10.1007/s11095-008-9540-4.